Related Experiment Video

Updated: Feb 7, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

54.1K

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment

Erin A Bohula1, Martin P Playford, Valentine M Macaulay

  • 1Cancer Research UK Laboratories, Weatherall Institute of Molecular Medicine, Oxford, UK.

Anti-Cancer Drugs
|October 11, 2003
PubMed

Insights

Targeting the type 1 insulin-like growth factor receptor (IGF1R) shows promise for cancer treatment by blocking tumor growth and enhancing drug sensitivity. Clinical trials are expected soon, offering potential against chemoresistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Type 1 insulin-like growth factor receptor (IGF1R) is overexpressed in many tumors.
  • IGF1R signaling drives tumor growth, motility, and apoptosis resistance.
  • Inhibiting IGF1R can block tumor progression and metastasis.

Purpose of the Study:

  • To review current strategies for targeting IGF1R in cancer therapy.
  • To discuss the therapeutic potential of IGF1R inhibition.
  • To highlight challenges and future directions for IGF1R-targeted treatments.

Main Methods:

  • Review of scientific literature on IGF1R targeting strategies.
  • Description of therapeutic agents including antibodies, small molecule inhibitors, antisense, and siRNA.
  • Discussion of potential clinical challenges and future clinical trials.

Main Results:

  • IGF1R inhibition effectively blocks tumor growth and metastasis.
  • Targeting IGF1R enhances sensitivity to chemotherapy and radiation.
  • Various molecular and antibody-based approaches are available for IGF1R targeting.

Conclusions:

  • IGF1R is a promising therapeutic target for various cancers.
  • Clinical trials are anticipated to evaluate IGF1R-targeting agents.
  • Potential challenges include normal tissue toxicity and cross-reactivity with the insulin receptor.

More Related Videos

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.7K
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

17.1K

Related Concept Videos

Factors Influencing Microbial Growth: pH01:29

Factors Influencing Microbial Growth: pH

Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.2K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
758
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.3K
Types of Receptors: Internal Receptors01:07

Types of Receptors: Internal Receptors

Many cellular signals are hydrophilic and cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind intracellular receptors that reside within the cell cytoplasm or nucleus. Many mammalian steroid hormones and nitric oxide (NO) gas use this cell signaling mechanism.
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
32.7K
Types of Receptors: Cell Surface Receptors01:28

Types of Receptors: Cell Surface Receptors

Cell-surface receptors, also known as transmembrane receptors, are cell surface, membrane-anchored (integral) proteins that bind to external ligand molecules. This type of receptor spans the plasma membrane and performs signal transduction, converting an extracellular signal into an intracellular signal. Ligands that interact with cell-surface receptors do not have to enter the cell that they affect. Cell-surface receptors are also called cell-specific proteins or markers because they are...
27.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K